Format

Send to

Choose Destination
J Am Geriatr Soc. 2012 May;60(5):946-50. doi: 10.1111/j.1532-5415.2012.03917.x. Epub 2012 Mar 28.

Effect of a disease-specific advance care planning intervention on end-of-life care.

Author information

1
School of Nursing, University of Wisconsin at Madison, Madison, Wisconsin, USA. ktkirchhoff@wisc.edu

Abstract

OBJECTIVES:

To compare patient preferences for end-of-life care with care received at the end of life.

DESIGN:

A randomized controlled trial was conducted with individuals with congestive heart failure or end-stage renal disease and their surrogates who were randomized to receive patient-centered advance care planning (PC-ACP) or usual care.

SETTING:

Two centers in Wisconsin with associated clinics and dialysis units.

PARTICIPANTS:

Of the 313 individuals and their surrogates who completed entry data, 110 died.

INTERVENTION:

During PC-ACP, the trained facilitator assessed individual and surrogate understanding of and experiences with the illness, provided information about disease-specific treatment options and their benefits and burden, assisted in documentation of treatment preferences, and assisted the surrogates in understanding the patient's preferences and the surrogate's role.

MEASUREMENTS:

Preferences were documented and compared with care received at the end of life according to surrogate interviews or medical charts.

RESULTS:

Patients (74%) frequently continued to make their own decisions about care to the end. The experimental group had fewer (1/62) cases in which patients' wishes about cardiopulmonary resuscitation were not met than in the control group (6/48) but not significantly so. Significantly more experimental patients withdrew from dialysis than controls.

CONCLUSION:

Patients and their surrogates were generally willing to discuss preferences with a trained facilitator. Most patients received the care they desired at end of life or altered their preferences to be in accord with the care they could receive. A larger sample with surrogate decision-makers is needed to detect significant differences.

Comment in

PMID:
22458336
PMCID:
PMC3354033
DOI:
10.1111/j.1532-5415.2012.03917.x
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center